Crestline Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-88,644
Closed -$8.82M 400
2024
Q4
$8.82M Buy
88,644
+79,826
+905% +$8.23M 0.29% 63
2024
Q3
$1M Buy
+8,818
New +$1.05M 0.05% 274
2018
Q3
Sell
-69,303
Closed -$4.01M 203
2018
Q2
$4.01M Buy
+69,303
New +$3.91M 0.42% 52

Other funds holding MRK

Crestline Management's MRK Position: Q1 2025 in Review

Crestline Management sold out of Merck (MRK) in Q1 2025, closing a stake of 88,644 shares — an estimated $8.82M sold.

Crestline Management first reported a position in MRK in Q2 2018 and held it in 3 quarters. The position peaked at $8.82M in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Crestline Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 88,644 Merck shares in Q1 2025, an estimated $8.82M.
  • Crestline Management first reported a position in Merck in Q2 2018 and held it in 3 quarters.
  • Crestline Management's Merck position peaked at $8.82M in Q4 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.